0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-29.45%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-61.53%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-496.72%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-496.72%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-64.24%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-27.12%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-27.12%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
29.22%
Share count expansion well above 0425.HK's 0.16%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
29.28%
Diluted share count expanding well above 0425.HK's 0.01%. Michael Burry would fear significant dilution to existing owners' stakes.
-100.00%
Dividend reduction while 0425.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-9.10%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-2.79%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-48.70%
Negative 10Y revenue/share CAGR while 0425.HK stands at 146.65%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-49.30%
Negative 5Y CAGR while 0425.HK stands at 35.83%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-53.69%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-963.10%
Negative 10Y OCF/share CAGR while 0425.HK stands at 47.19%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-956.34%
Negative 5Y OCF/share CAGR while 0425.HK is at 85.20%. Joel Greenblatt would question the firm’s operational model or cost structure.
-34.05%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-208.22%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-514.36%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-282.74%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
135.21%
10Y equity/share CAGR at 75-90% of 0425.HK's 151.97%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
-6.80%
Negative 5Y equity/share growth while 0425.HK is at 57.95%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-26.90%
Negative 3Y equity/share growth while 0425.HK is at 24.74%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while 0425.HK stands at 513.28%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while 0425.HK stands at 48.16%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while 0425.HK invests at 1.87%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-5.13%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
22.07%
Inventory growth well above 0425.HK's 1.68%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
9.37%
Asset growth above 1.5x 0425.HK's 3.35%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-26.90%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
73.53%
Debt growth far above 0425.HK's 46.18%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-37.45%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-33.04%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.